Interstitial lung disease appears to be a risk factor for radiation pneumonitis, a potentially life-threatening adverse effect of radiotherapy to the chest and thorax.
[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.
High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.
What is the best approach to learning more about the field of Radiation Oncology?
Is there a difference in dosing (1 hour prior to radiotherapy vs bedtime) with temozolomide plus radiotherapy for glioblastoma multiforme?
Is combination therapy of imatinib (Gleevec) and radiotherapy safe?
Sexual dysfunction is a common and distressing side effect of prostate cancer treatment. Two new reports from randomized clinical trials offer mixed results for adjuvant pharmacotherapy intended to prevent erectile dysfunction in men undergoing radiotherapy for prostate cancer.
Erythropoietin plus radiation does not improve local-regional control in anemic patients with head and neck cancer
The addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma (HNSCC) who receive radiation therapy.
Two case studies have described what is believed to be the first reported successful use of stereotactic body radiation therapy for an oft-deadly kidney cancer complication.
Three weeks after a multidimensional intervention, 90% of patients with head and neck cancer undergoing radiation reported full adherence.
Two studies do not show protective effect of delayed radiation compared to earlier radiation for prostate cancer.
Present barriers for the usual dosimetry accompanying photodynamic therapy (PDT) for late-stage pancreatic cancer can be overcome via clinical technologies.
EPO plus radiotherapy does not improve local-regional control in anemic patients with head and neck cancer
Combination erythropoietin and radiation therapy did not improve control for anemic patients with head and neck squamous cell carcinoma.
A gap exists between patient expectations and current practices for provision of information about radiation use.
New evidence indicates that combining chemotherapy with radiation therapy may be the best option for people with a low-grade form of brain cancer.
Patients with cancer desire more information from health care professionals about medical imaging tests that use radiation.
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
- 'Bathing and Honoring' Intervention Benefits Families After Acute Care Patient Death
- Previvorship: Managing Cancer Risk Decisions in Unaffected BRCA-positive Women
- Low vitamin D linked to worse prognosis in a type of non-Hodgkin lymphoma
- Risk of ovarian cancer may differ by type of BRCA1 or BRCA2 mutation
- New treatment options discovered for colorectal tumors
- Exercise slows tumor growth and improves chemotherapy
- Educational Walk Through Colon Promotes Colorectal Cancer Screening
- Function of a micron filter
- Kaizen Huddle Boards Enhance Patient Care, Reduces Waste in Ambulatory Center
- Validating Chemotherapy Administration Feasible with Simulation-Based Evaluation
- Physical activity benefits lung cancer patients and survivors
- Lifetime vigorous physical activity may be beneficial in lowering risk for non-Hodgkin lymphoma
- Statin use before, after lung cancer diagnosis may reduce risk of cancer-related death
- Replacing one serving of sugary drink every day may lower diabetes risk
- MRI screening program for persons at high risk of pancreatic cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|